TY - JOUR
T1 - Tuberculosis screening in a novel substance abuse treatment center in Malaysia
T2 - Implications for a comprehensive approach for integrated care
AU - Al-Darraji, Haider Abdulrazzaq Abed
AU - Wong, Kee Cheong
AU - Yeow, David Gan Eng
AU - Fu, Jeannia Jiani
AU - Loeliger, Kelsey
AU - Paiji, Christopher
AU - Kamarulzaman, Adeeba
AU - Altice, Frederick L.
N1 - Funding Information:
The authors would like to thank the director and the staff of the National Anti-Drug Agency (NADA) in Malaysia for their support in conducting the research in their facility. The funding for this research was provided by the University of Malaya HIR Grant ( HIRGA E000001-20001 ) and the National Institutes on Drug Abuse for Research ( R01 DA025943 ) and Career Development Award for FLA ( K24 DA017072 ). Part of the study was orally presented at the 43rd Union World Conference on Lung Health, Kuala Lumpur, 13–17 November 2012.
PY - 2014/2
Y1 - 2014/2
N2 - People who use drugs (PWUD) represent a key high risk group for tuberculosis (TB). The prevalence of both latent TB infection (LTBI) and active disease in drug treatment centers in Malaysia is unknown. A cross-sectional convenience survey was conducted to assess the prevalence and correlates of LTBI among attendees at a recently created voluntary drug treatment center using a standardized questionnaire and tuberculin skin testing (TST). Participants (N= 196) were mostly men (95%), under 40 (median age = 36. years) and reported heroin use immediately before treatment entry (75%). Positive TST prevalence was 86.7%. Nine (4.6%) participants were HIV-infected. Previous arrest/incarcerations (AOR = 1.1 for every entry, p< 0.05) and not being HIV-infected (AOR = 6.04, p= 0.03) were significantly associated with TST positivity. There is an urgent need to establish TB screening and treatment programs in substance abuse treatment centers and to tailor service delivery to the complex treatment needs of patients with multiple medical and psychiatric co-morbidities.
AB - People who use drugs (PWUD) represent a key high risk group for tuberculosis (TB). The prevalence of both latent TB infection (LTBI) and active disease in drug treatment centers in Malaysia is unknown. A cross-sectional convenience survey was conducted to assess the prevalence and correlates of LTBI among attendees at a recently created voluntary drug treatment center using a standardized questionnaire and tuberculin skin testing (TST). Participants (N= 196) were mostly men (95%), under 40 (median age = 36. years) and reported heroin use immediately before treatment entry (75%). Positive TST prevalence was 86.7%. Nine (4.6%) participants were HIV-infected. Previous arrest/incarcerations (AOR = 1.1 for every entry, p< 0.05) and not being HIV-infected (AOR = 6.04, p= 0.03) were significantly associated with TST positivity. There is an urgent need to establish TB screening and treatment programs in substance abuse treatment centers and to tailor service delivery to the complex treatment needs of patients with multiple medical and psychiatric co-morbidities.
KW - HIV
KW - Integration
KW - Malaysia
KW - Substance use
KW - Tuberculosis
UR - https://www.scopus.com/pages/publications/84888200062
U2 - 10.1016/j.jsat.2013.08.023
DO - 10.1016/j.jsat.2013.08.023
M3 - Article
C2 - 24074846
AN - SCOPUS:84888200062
SN - 0740-5472
VL - 46
SP - 144
EP - 149
JO - Journal of Substance Abuse Treatment
JF - Journal of Substance Abuse Treatment
IS - 2
ER -
SDG 3 Good Health and Well-being